ClotProtect is a Leeds-based medtech company focused on creating innovative solutions that lower the incidence and complications of blood clots in patients. Founded by Helen Philippou, the firm aims to enhance patient safety through proprietary technology that addresses a critical healthcare challenge. After participating in Lifted Ventures’ Elevate Her Accelerator, ClotProtect received continued mentorship and support that helped it refine its product and fundraising strategy. The company plans to use newly secured capital to advance product development, navigate regulatory and clinical pathways, and prepare for wider commercial rollout. Its leadership views access to both private and public funding as key to accelerating growth and de-risking early-stage development. By combining technical innovation with strong clinical focus, ClotProtect aspires to scale its technology to reach a broader patient population. Specific operating metrics such as revenue or user numbers were not disclosed in the article.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2026